AstraZeneca expands Canada R&D work, to add 500 jobs
AstraZeneca will expand its Canada R&D footprint, expanding its center near Toronto and creating a new rare diseases research center there with its Alexion unit, the company said.
The UK drugmaker said the expansion will add 500 jobs. The existing operations there help run many of AstraZeneca’s clinical trials, according to the release. Currently, AstraZeneca has about 1,200 employees in the country, mostly at its hub in the Toronto suburbs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.